266 related articles for article (PubMed ID: 23278576)
1. Synaptic basal lamina-associated congenital myasthenic syndromes.
Maselli RA; Arredondo J; Ferns MJ; Wollmann RL
Ann N Y Acad Sci; 2012 Dec; 1275():36-48. PubMed ID: 23278576
[TBL] [Abstract][Full Text] [Related]
2. Developmental consequences of the ColQ/MuSK interactions.
Karmouch J; Dobbertin A; Sigoillot S; Legay C
Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
[TBL] [Abstract][Full Text] [Related]
3. COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.
Arredondo J; Lara M; Ng F; Gochez DA; Lee DC; Logia SP; Nguyen J; Maselli RA
Hum Genet; 2014 May; 133(5):599-616. PubMed ID: 24281389
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
[TBL] [Abstract][Full Text] [Related]
6. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
Ohno K; Ito M; Masuda A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional organization of synaptic acetylcholinesterase.
Aldunate R; Casar JC; Brandan E; Inestrosa NC
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):96-104. PubMed ID: 15572165
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
[TBL] [Abstract][Full Text] [Related]
10. Targeting acetylcholinesterase to the neuromuscular synapse.
Rotundo RL; Rossi SG; Kimbell LM; Ruiz C; Marrero E
Chem Biol Interact; 2005 Dec; 157-158():15-21. PubMed ID: 16289417
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterases and the basal lamina at vertebrate neuromuscular junctions.
Massoulié J; Millard CB
Curr Opin Pharmacol; 2009 Jun; 9(3):316-25. PubMed ID: 19423392
[TBL] [Abstract][Full Text] [Related]
12. Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations.
Ito M; Ohno K
Matrix Biol; 2018 Aug; 68-69():628-636. PubMed ID: 29475025
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
[TBL] [Abstract][Full Text] [Related]
14. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction.
Cartaud A; Strochlic L; Guerra M; Blanchard B; Lambergeon M; Krejci E; Cartaud J; Legay C
J Cell Biol; 2004 May; 165(4):505-15. PubMed ID: 15159418
[TBL] [Abstract][Full Text] [Related]
15. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
[TBL] [Abstract][Full Text] [Related]
16. Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms.
Legay C
Ann N Y Acad Sci; 2018 Feb; 1413(1):104-110. PubMed ID: 29405353
[TBL] [Abstract][Full Text] [Related]
17. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
Müller JS; Mihaylova V; Abicht A; Lochmüller H
Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
[TBL] [Abstract][Full Text] [Related]
18. Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene.
Müller JS; Petrova S; Kiefer R; Stucka R; König C; Baumeister SK; Huebner A; Lochmüller H; Abicht A
Neuropediatrics; 2004 Jun; 35(3):183-9. PubMed ID: 15248101
[TBL] [Abstract][Full Text] [Related]
19. Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency.
Ishigaki K; Nicolle D; Krejci E; Leroy JP; Koenig J; Fardeau M; Eymard B; Hantaï D
Neuromuscul Disord; 2003 Mar; 13(3):236-44. PubMed ID: 12609505
[TBL] [Abstract][Full Text] [Related]
20. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
